GSK3b and dsRNA in CD8 cells
GSK3b and dsRNA in CD8 cells
批准号:
10656501
负责人:
Mercedes Rincon
金额:
$19.44万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-07-01 至 2024-06-30
关键词:
Autoimmune DiseasesCD8-Positive T-LymphocytesCellsDouble-Stranded RNAFailureGAG GeneHexachlorobenzeneHomeostasisImmune responseInfectionInnate Immune ResponseInterferonsMitochondriaMolecularPathway interactionsPatternPhosphorylationPlayProductionRegulationRoleSourceT cell responseT-LymphocyteTestingTranscriptVirusVirus Diseasescytokinenovelpathogenresponse
中文摘要
项目概要
双链 RNA (dsRNA) 是一种众所周知的病原体相关分子模式 (PAMP)
病毒感染期间产生,可触发先天免疫反应,并在病毒感染中发挥关键作用
通过直接作用于 I 型干扰素来提供保护。然而,近年来,这一途径已明确
也可以由内源性 dsRNA 诱导,线粒体转录物是 dsRNA 的主要来源之一
内源性双链RNA。内源 dsRNA 的存在表明必须有适当的机制来
继续检查它们的积累以避免触发 RLR 途径。尽管有大量研究表明
内源性 dsRNA 产生的 I 型干扰素如何间接调节 T 细胞反应,没有
之前的研究已经检查了 T 细胞中的 dsRNA。我们最近的研究揭示了内源性的存在
CD8 细胞中的 dsRNA 激活后,线粒体似乎是主要来源。此外,我们还确定
CD8 细胞用来限制 dsRNA 生成水平的新机制:线粒体失活
GSK3 通过 Ser389 磷酸化。有趣的是,磷酸化 Ser389 未能灭活 GSK3 会导致
活化的 CD8 细胞中线粒体 dsRNA 的积累量更大。重要的是,我们还发现未能
通过磷酸化 Ser389 灭活 GSK3 会导致 CD8 细胞产生更高水平的 IFN。我们假设
线粒体 dsRNA 在 CD8 细胞激活过程中产生,可以触发 RLR 通路并有助于
以维持干扰素的产生。我们还提出线粒体 GSK3 干扰线粒体
降解体和线粒体 GSK3 通过 Ser389 磷酸化来失活
dsRNA 对于维持 dsRNA 稳态和限制 IFNγ 的产生至关重要。我们将测试这个
具有以下具体目的的假设:1)表明线粒体 dsRNA 在激活过程中生成
CD8 细胞并有助于 IFNγ 的产生。 2) 表明 GSK3 通过 Ser389- 失活
磷酸化在 CD8 细胞激活过程中线粒体 dsRNA 的稳态中发挥作用。的
拟议研究的结果可能是一个重大突破,因为它们将展示内源 dsRNA 如何
有助于维持活化 CD8 细胞中细胞因子的产生,及其对自身免疫的潜在影响
疾病。
英文摘要
PROJECT SUMMARY
Double-stranded RNA (dsRNA) is a well-known pathogen-associated molecular pattern (PAMP)
generated during viral infections that triggers the innate immune response and plays a critical role in virus
protection through the direct effect on type I IFN. However, in recent years it has been clear that this pathway
can also be induced by endogenous dsRNA, with mitochondria transcripts being one of the major sources of
endogenous dsRNA. The presence of endogenous dsRNA suggests that there must be mechanisms in place to
keep on check their accumulation to avoid triggering RLRs pathways. Although there is a number of studies on
how the production of type I IFN resulting from endogenous dsRNA can indirectly modulate T cell response, no
previous studies have examined dsRNA in T cells. Our recent studies have revealed the presence of endogenous
dsRNA in CD8 cells upon activation, and mitochondria seems to be the primary source. In addition, we identify
a new mechanism that CD8 cells use to restrict the levels of dsRNA generated: inactivation of mitochondria
GSK3 by phosphorylation on Ser389. Interestingly, failure to inactivate GSK3 by phospho-Ser389 results in a
greater accumulation of mitochondrial dsRNA in activated CD8 cells. Importantly, we also found that failure to
inactivate GSK3 by phospho-Ser389 results in higher levels of IFN produced by CD8 cells. We hypothesize that
mitochondrial dsRNAs are generated during activation of CD8 cells, can trigger the RLR pathway and contribute
to sustain IFN production. We also propose that mitochondrial GSK3 interferes with the mitochondrial
degradosome and that inactivation of mitochondrial GSK3 through phosphorylation on Ser389 in response to
dsRNA is essential for maintaining dsRNA-homeostasis and restricting IFN production. We will test this
hypothesis with the following specific aims: 1) to show that mitochondrial dsRNA is generated during activation
of CD8 cells and contributes to the production of IFN. 2) to show that inactivation of GSK3 through Ser389-
phosphorylation plays a role in the homeostasis of mitochondrial dsRNA during activation of CD8 cells. The
results from the proposed studies could be a major breakthrough since they will show how endogenous dsRNA
can contribute to sustain cytokine production in activated CD8 cells, and its potential impact on autoimmune
disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GSK3b and dsRNA in CD8 cells
-
批准号:10536526
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2022
-
负责人:Mercedes Rincon
-
依托单位:
Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response
-
批准号:10578743
-
项目类别:
-
资助金额:$37.04万
-
财政年份:2022
-
负责人:Mercedes Rincon
-
依托单位:
Targeting mitochondrial regulator MCJ to enhance CD8 cell immune response
-
批准号:10293952
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2020
-
负责人:Mercedes Rincon
-
依托单位:
Fine-tuning of mitochondrial Complex I activity in CD8 cells
-
批准号:10092947
-
项目类别:
-
资助金额:$19.45万
-
财政年份:2020
-
负责人:Mercedes Rincon
-
依托单位:
Fostering entrepreneurship in biomedical research
-
批准号:8998210
-
项目类别:
-
资助金额:$44.01万
-
财政年份:2016
-
负责人:Mercedes Rincon
-
依托单位:
IL-6: an innate immune regulator for the plasticity of Tfh cells
-
批准号:8434542
-
项目类别:
-
资助金额:$44.13万
-
财政年份:2012
-
负责人:Mercedes Rincon
-
依托单位:
COBRE: UVT: CORE TRANSGENIC ANIMAL PROGRAM: MOUSE GENOMIC DNA BAC LIBRARY
-
批准号:7959621
-
项目类别:
-
资助金额:$20.58万
-
财政年份:2009
-
负责人:Mercedes Rincon
-
依托单位:
MCJ function in mouse mammary tumor properties
-
批准号:7807612
-
项目类别:
-
资助金额:$9.93万
-
财政年份:2008
-
负责人:Mercedes Rincon
-
依托单位:
COBRE: UVT: CORE TRANSGENIC ANIMAL PROGRAM: MOUSE GENOMIC DNA BAC LIBRARY
-
批准号:7720875
-
项目类别:
-
资助金额:$19.16万
-
财政年份:2008
-
负责人:Mercedes Rincon
-
依托单位:
MCJ function in mouse mammary tumor properties
-
批准号:7390544
-
项目类别:
-
资助金额:$16.95万
-
财政年份:2008
-
负责人:Mercedes Rincon
-
依托单位:
MCJ function in mouse mammary tumor properties
-
批准号:7582309
-
项目类别:
-
资助金额:$16.93万
-
财政年份:2008
-
负责人:Mercedes Rincon
-
依托单位:
COBRE: UVT: CORE TRANSGENIC ANIMAL PROGRAM: MOUSE GENOMIC DNA BAC LIBRARY
-
批准号:7609699
-
项目类别:
-
资助金额:$24.73万
-
财政年份:2007
-
负责人:Mercedes Rincon
-
依托单位:
COBRE: UVT: CORE TRANSGENIC ANIMAL PROGRAM: MOUSE GENOMIC DNA BAC LIBRARY
-
批准号:7381077
-
项目类别:
-
资助金额:$26.02万
-
财政年份:2006
-
负责人:Mercedes Rincon
-
依托单位:
COBRE: UVT:CORE TRANSGENIC ANIMAL PROGRAM: MOUSE GENOMIC
-
批准号:7170236
-
项目类别:
-
资助金额:$21.12万
-
财政年份:2005
-
负责人:Mercedes Rincon
-
依托单位:
CORE--TRANSGENIC ANIMAL PROGRAM: MOUSE GENOMIC DNA BAC LIBRARY
-
批准号:7011653
-
项目类别:
-
资助金额:$18.2万
-
财政年份:2004
-
负责人:Mercedes Rincon
-
依托单位:
p38 MAP kinase in early thymocyte development
-
批准号:7617775
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2002
-
负责人:Mercedes Rincon
-
依托单位:
NFAT in naive, effector and memory Th1 and Th2 cells
-
批准号:6644941
-
项目类别:
-
资助金额:$15.92万
-
财政年份:2002
-
负责人:Mercedes Rincon
-
依托单位:
p38 MAP kinase in early thymocyte development
-
批准号:7649702
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2002
-
负责人:Mercedes Rincon
-
依托单位:
GSK3B in TCR repertoire and immune diseases
-
批准号:9326896
-
项目类别:
-
资助金额:$38.88万
-
财政年份:2002
-
负责人:Mercedes Rincon
-
依托单位:
p38 MAP kinase in early thymocyte development
-
批准号:8013616
-
项目类别:
-
资助金额:$36.88万
-
财政年份:2002
-
负责人:Mercedes Rincon
-
依托单位:
海外基金